The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Circulating Pregenomic HBV RNA is Primarily Full-length in Chronic Hepatitis B Patients Undergoing Nucleos(t)ide Analogue Therapy
Mark Anderson1, Jeffery Gersch1, Ka-Cheung Luk1, George Dawson1, Ivana Carey2, Kosh Agarwal3, Pir Shah4, Geoffrey Dusheiko3, Daryl Lau5, Gavin Cloherty1
Author information
1Abbott Laboratories, Abbott Diagnostics Division, Abbott Park, Illinois.
2King's College, London, United Kingdom.
3Institute of Liver Studies, King's College Hospital, London, United Kingdom.
4Harvard University, Boston, Massachusetts.
5Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Abstract
HBV RNA is detectable in the serum of infected patients, however the RNA species has been questioned. We tested 1827 specimens using a quantitative dual-target qPCR assay and determined full-length pregenomic RNA is the primary source. These results clarify the major identity of circulating HBV RNA species.